Befejeződött1. fázis
A Study to Evaluate Safety, Pharmacokinetics, and Preliminary Clinical Activity of RO7276389 Alone and in Combination with Cobimetinib in Participants with BRAF-V600 Mutation-Positive Advanced Solid Tumor or BRAF-V600 Mutation-Positive Melanoma with Central Nervous System Metastases
Key facts
- Where
- Barcelona, Madrid és Pamplona, SpanyolországSee the 4 sites
- Phase
- 1. fázis
Where in Spanyolország
- Vall D'hebron Institut De RecercaBarcelona, SpanyolországNo longer taking part
- Clinica Universidad de NavarraMadrid, SpanyolországNo longer taking part
- Hospital Universitario HM SanchinarroMadrid, SpanyolországNo longer taking part
- Clínica Universidad de navarraPamplona, SpanyolországNo longer taking part
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2023-506310-43-00
- Record updated
- 2025. december 5.